The goal of this study is to determine the safety and efficacy of the administration of
vitamin E, which has been shown to delay the progression of Alzheimer's disease, in slowing
the rate of cognitive/functional decline in older persons with Down syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
New York State Institute for Basic Research
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Center for Complementary and Integrative Health (NCCIH) National Institute on Aging (NIA)
Treatments:
alpha-Tocopherol Tocopherols Tocotrienols Vitamin E Vitamins